5-Amino-1MQ 50 mg vial
- RUO$58Listed price · deal not verifiedCOA tested Jun 16, 2026
- Ameano Peptides$68Listed priceCOA tested Apr 27, 2026
- EZ Peptides$68Listed price · deal not verifiedCOA tested Apr 23, 2026
5-Amino-1MQ is a small-molecule research compound, not a peptide, studied as an inhibitor of nicotinamide N-methyltransferase (NNMT).
Also known as 5 amino 1 mq · 5 amino 1mq · 5-amino · 5-amino 1 mq · 5-amino 1mq · 5-amino-1 mq
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
4 of 6 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: 5-Amino-1MQ COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $0.80 | $2.50 | 57 | 93 | |
| $0.54 | $2.52 | 53 | 83 | |
| $0.90 | $2.94 | 30 | 58 | |
| $0.56 | $2.30 | 14 | 33 |
What it is
5-Amino-1MQ is a small-molecule research compound, not a peptide, studied as an inhibitor of nicotinamide N-methyltransferase (NNMT).
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
This exact-name search did not return a reliable PubMed or ClinicalTrials.gov match in the bounded run. Metabolic and body-composition marketing around the compound therefore remains unsupported by the retained source set for this entry.
Search indexed research for this compound ↗Market context
5-Amino-1MQ is commonly sold or discussed for weight management, energy use, glucose control, and body composition research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Amino Science | Grade A- | 1 | 1 | $42.99 · 10 mg vialObserved Nov 14, 2026 |
| EZ Peptides | Grade A- | 1 | 1 | $68 · 50 mg vialObserved Nov 14, 2026 |
| Peptide Plugs | Grade A- | 2 | 2 | $30 · 10 mg vialObserved Nov 14, 2026 |
| Ascension Peptides | Grade A- | 1 | 1 | $52 · 10 mg vialObserved Nov 14, 2026 |
| Evolve Peptides | Grade A- | 1 | 1 | $134.90 · 50 mg capsule · pack of 60Observed Nov 14, 2026 |
| GenPeptide | Grade A- | 1 | 1 | $60 · 50 mg vialEarlier observation Oct 20, 2026 |
| Bulk Peptide Supply | Grade B+ | 3 | 3 | $20 · 50 mg vialObserved Nov 14, 2026 |
| Ameano Peptides | Grade B+ | 1 | 1 | $68 · 50 mg vialObserved Nov 14, 2026 |
| Blue Ridge Peptides | Grade B+ | 1 | 1 | $75 · 50 mg vialObserved Nov 14, 2026 |
| Alpha Peps | Grade B+ | 2 | 2 | $55 · 10 mg vialObserved Nov 14, 2026 |
| Alpha Pro Peptides | Grade B+ | 1 | 1 | $27.50 · 10 mg vialObserved Nov 14, 2026 |
| Prime Lab Peptides | Grade B+ | 2 | 2 | $45 · 10 mg vialEarlier observation Oct 28, 2026 |
| Oasis Peptides | Grade B+ | 2 | 2 | $60 · 10 mg vialObserved Nov 14, 2026 |
| Oros Research | Grade B+ | 1 | 1 | $64.99 · 50 mg vialEarlier observation Oct 29, 2026 |
| RIVN Peptides | Grade B+ | 1 | 1 | $25 · 10 mg vialObserved Nov 14, 2026 |
| Ignite Peptides | Grade B | 1 | 1 | $25 · 5 mg vialObserved Nov 14, 2026 |
| TCore Biotech | Grade B | 1 | 1 | $35.19 · 5 mg vialObserved Nov 14, 2026 |
| Biolongevity Labs | Grade B | 1 | 1 | $74.97 · 10 mg vialObserved Nov 14, 2026 |
| Coffee and Peppers | Grade B | 3 | 2 | $54.99 · 10 mg vialEarlier observation Oct 4, 2026 · out of stock |
| RUO | Grade B | 1 | 1 | $58 · 50 mg vialObserved Nov 14, 2026 |
| NuLife Peptides | Grade B | 1 | 1 | $52 · 50 mg vialEarlier observation Oct 17, 2026 |
| Premier Bio Labs | Grade A- | 2 | 2 | $69 · 50 mg vialEarlier observation Sep 21, 2026 |
| Swiss Chems | Grade C | 1 | 1 | $119.99 · 50 mg capsule · pack of 60Observed Nov 14, 2026 |
| AIO Peptides | Not graded | 1 | 1 | $54.40 · 10 mg vialObserved Nov 14, 2026 |
| Next Chems | Not graded | 1 | 1 | $119.99 · 50 mg capsule · pack of 60Observed Nov 14, 2026 |
| Nova Life Peptides | Not graded | 1 | 1 | $20 · 5 mg vialObserved Nov 14, 2026 |
| Peptides 4 Research | Not graded | 2 | 2 | $68 · 10 mg vialObserved Nov 14, 2026 |
| Pharma Grade Peptides | Not graded | 1 | 1 | $149.99 · 50 mg vialObserved Nov 14, 2026 |
| Skye Peptides | Not graded | 1 | 1 | $89 · 50 mg vialObserved Nov 14, 2026 |
34 tracked vendors list 5-Amino-1MQ without a current offer: Nura Peptide (Grade A-), Orbitrex Peptides (Grade A-), Puratek Peptides (Grade A-), Southern Aminos (Grade A-), Rocky Mountain Compounds (Grade B+), Voltera Sciences (Grade B+), Glacier Aminos (Grade B+), Panda Peptides (Grade B+), Peptide Partners (Grade B+), Peptide Crafters (Grade B+), MedVinci Research (Grade B+), Licensed Peptides (Grade B+), SaiyanMed (Grade B+), Simple Peptide (Grade B), Ion Peptides (Grade B), Paramount Peptides (Grade B), Chameleon Peptides (Grade B), Eternal Peptides (Grade B), Nationwide Peptides (Grade B+), VAYN (Grade B), NextGen Peptides (Grade B), Royal Peptides (Grade B), Vital Core Research (Grade B), Mile High Compounds (Grade B), NextechLabs (Grade C), Peptidology (Grade C), Oath Research (Grade C), American Peptide Research (Not graded), Atomik Labz (Not graded), Northline Labs (Not graded), Nuscience Peptides (Not graded), Planet Peptide (Not graded), Pura Peptides (Not graded), Tydes (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.